Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIKACIN vs STREPTOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIKACIN vs STREPTOMYCIN: Safety Overview

Metric AMIKACIN STREPTOMYCIN
Total FAERS Reports 11,312 344
Deaths Reported 2,114 44
Death Rate 18.7% 12.8%
Hospitalizations 4,686 136
Average Patient Age 54.3 yrs 44.3 yrs
% Female Patients 57.4% 31.7%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Insmed Incorporated XGen Pharmaceuticals DJB, Inc.
Route RESPIRATORY (INHALATION) INTRAMUSCULAR
Marketing Status Discontinued Discontinued